These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 16268667)
21. Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage. Giladi N; Nicholas AP; Asgharnejad M; Dohin E; Woltering F; Bauer L; Poewe W J Parkinsons Dis; 2016 Oct; 6(4):741-749. PubMed ID: 27567886 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease. Hauser RA; Slawek J; Barone P; Dohin E; Surmann E; Asgharnejad M; Bauer L BMC Neurol; 2016 Jun; 16():90. PubMed ID: 27267880 [TBL] [Abstract][Full Text] [Related]
24. Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study. Mizuno Y; Nomoto M; Hasegawa K; Hattori N; Kondo T; Murata M; Takeuchi M; Takahashi M; Tomida T; Parkinsonism Relat Disord; 2014 Dec; 20(12):1388-93. PubMed ID: 25455692 [TBL] [Abstract][Full Text] [Related]
25. Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. LeWitt PA; Boroojerdi B; MacMahon D; Patton J; Jankovic J Clin Neuropharmacol; 2007; 30(5):256-65. PubMed ID: 17909303 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Poewe WH; Rascol O; Quinn N; Tolosa E; Oertel WH; Martignoni E; Rupp M; Boroojerdi B; Lancet Neurol; 2007 Jun; 6(6):513-20. PubMed ID: 17509486 [TBL] [Abstract][Full Text] [Related]
27. Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study. Chung SJ; Kim JM; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L; Expert Opin Pharmacother; 2015 May; 16(7):961-70. PubMed ID: 25846031 [TBL] [Abstract][Full Text] [Related]
28. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study. Kim JM; Chung SJ; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L; BMC Neurol; 2015 Feb; 15():17. PubMed ID: 25879416 [TBL] [Abstract][Full Text] [Related]
29. Night-time use of rotigotine in advanced Parkinson's disease. Canesi M; Mariani CB; Isaias IU; Pezzoli G Funct Neurol; 2010; 25(4):201-4. PubMed ID: 21388580 [TBL] [Abstract][Full Text] [Related]
30. Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Nomoto M; Mizuno Y; Kondo T; Hasegawa K; Murata M; Takeuchi M; Ikeda J; Tomida T; Hattori N J Neurol; 2014 Oct; 261(10):1887-93. PubMed ID: 25022939 [TBL] [Abstract][Full Text] [Related]
31. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial. Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Trenkwalder C; Benes H; Poewe W; Oertel WH; Garcia-Borreguero D; de Weerd AW; Ferini-Strambi L; Montagna P; Odin P; Stiasny-Kolster K; Högl B; Chaudhuri KR; Partinen M; Schollmayer E; Kohnen R; Lancet Neurol; 2008 Jul; 7(7):595-604. PubMed ID: 18515185 [TBL] [Abstract][Full Text] [Related]
33. Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. Pierantozzi M; Placidi F; Liguori C; Albanese M; Imbriani P; Marciani MG; Mercuri NB; Stanzione P; Stefani A Sleep Med; 2016 May; 21():140-4. PubMed ID: 27448485 [TBL] [Abstract][Full Text] [Related]
34. Novel UHPLC-MS/MS method for the determination of rotigotine in the plasma of patients with Parkinson's disease. Mohamed S; Riva R; Contin M Biomed Chromatogr; 2017 Sep; 31(9):. PubMed ID: 28168729 [TBL] [Abstract][Full Text] [Related]